Reckitt Benckiser Sheds Nearly $7 Billion in Market Value After Infant-Formula Verdict — Update
By Michael Susin
Reckitt Benckiser lost almost $7 billion in market value after a jury in an Illinois court sided with a plaintiff in a case relating to its Enfamil infant formula.
London-listed shares in the U.K. consumer-goods company closed nearly 15% lower at GBP44.86 on Friday, according to FactSet, giving the group a market value of almost GBP31.95 billion ($40.74 billion).
The rout came after it was reported that an Illinois jury ordered the company's infant-formula unit, Mead Johnson, to pay $60 million in compensation related to the death of a premature baby who was fed Enfamil.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said Friday that it strongly disagrees with the jury's decision to fault Mead Johnson and that it doesn't believe any of its products cause necrotizing enterocolitis, a life-threatening gastrointestinal disease.
"We will pursue all options to overturn the verdict," it said, adding that the allegations from the plaintiff weren't supported by the science.
Mead Johnson Nutrition Company was acquired by Reckitt in June 2017.
"Based on the size of this fine, the share move is massively overstating the initial impact, which suggests investors are preparing for more to come," Hargreaves Lansdown head of money and markets, Susannah Streeter, said in market comment.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
March 15, 2024 14:03 ET (18:03 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Top-Performing Dividend Stocks of Q3 2024
-
33 Undervalued Stocks
-
Communication Services: Cable’s Broadband Dominance Isn’t as Strong as It Once Was
-
Technology: Strength Continues, With Software Presenting the Best Buying Opportunities
-
Best- and Worst-Performing Stocks of Q3 2024
-
Top Stocks to Own From the Best Fund Managers
-
2 Cheap Stocks Top Managers Have Been Buying
-
The 10 Best Companies to Invest in Now